Shares of Synopsys, Inc. (NASDAQ:SNPS) have earned an average recommendation of “Hold” from the twelve analysts that are presently covering the company, MarketBeat reports. Two analysts have rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the company. The average 1 year price target among analysts that have covered the stock in the last year is $98.71.
A number of brokerages have recently issued reports on SNPS. JPMorgan Chase & Co. cut shares of Synopsys from a “neutral” rating to an “underweight” rating and set a $87.00 price objective for the company. in a research note on Tuesday, December 12th. BidaskClub cut shares of Synopsys from a “buy” rating to a “hold” rating in a research note on Friday, February 2nd. KeyCorp restated an “overweight” rating and issued a $106.00 price objective (up previously from $86.00) on shares of Synopsys in a research note on Thursday, November 30th. TheStreet cut shares of Synopsys from an “a” rating to a “c+” rating in a research note on Wednesday, November 29th. Finally, Needham & Company LLC increased their price objective on shares of Synopsys from $83.00 to $100.00 and gave the company a “buy” rating in a research note on Friday, December 1st.
In other news, CEO Chi-Foon Chan sold 3,750 shares of the company’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $89.78, for a total value of $336,675.00. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Steven Walske sold 4,545 shares of the company’s stock in a transaction dated Wednesday, January 17th. The stock was sold at an average price of $90.12, for a total transaction of $409,595.40. Following the completion of the sale, the director now directly owns 14,988 shares in the company, valued at approximately $1,350,718.56. The disclosure for this sale can be found here. In the last ninety days, insiders sold 65,442 shares of company stock worth $5,779,693. 1.82% of the stock is owned by insiders.
Shares of Synopsys (NASDAQ SNPS) traded up $0.90 during mid-day trading on Friday, hitting $83.52. 1,125,101 shares of the stock were exchanged, compared to its average volume of 939,735. Synopsys has a 52 week low of $65.07 and a 52 week high of $94.80. The firm has a market cap of $12,767.07, a PE ratio of 97.95, a price-to-earnings-growth ratio of 3.83 and a beta of 1.04. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.04.
Synopsys (NASDAQ:SNPS) last announced its quarterly earnings data on Wednesday, November 29th. The semiconductor company reported $0.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.57 by $0.12. Synopsys had a net margin of 5.01% and a return on equity of 5.78%. The company had revenue of $696.60 million during the quarter, compared to analysts’ expectations of $650.72 million. During the same quarter in the prior year, the company posted $0.77 EPS. The business’s revenue was up 9.9% on a year-over-year basis. research analysts forecast that Synopsys will post 2.24 EPS for the current year.
ILLEGAL ACTIVITY WARNING: “Synopsys, Inc. (SNPS) Given Consensus Rating of “Hold” by Brokerages” was published by American Banking News and is the property of of American Banking News. If you are reading this news story on another publication, it was illegally copied and republished in violation of United States & international copyright law. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2018/02/09/synopsys-inc-snps-given-consensus-rating-of-hold-by-brokerages.html.
Synopsys, Inc provides software, intellectual property (IP) and services. The Company supplies the electronic design automation (EDA) software that engineers use to design and test integrated circuits, also known as chips. It also offers IP products, which are pre-designed circuits that engineers use as components of larger chip designs rather than designing those circuits themselves.
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.